Estrogen receptor β2 and β5 are associated with poor prognosis in prostate cancer, and promote cancer cell migration and invasion

Endocrine-Related Cancer

Volumn 17, Issue 3, 2010, Pages 675-689

  Leung, Yuet Kin ^a,b   Lam, Hung Ming ^a   Wu, Shulin ^c   Song, Dan ^a   Levin, Linda ^a   Cheng, Liang ^d   Wu, Chin Lee ^c   Ho, Shuk Mei ^a,b  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR BETA; ESTROGEN RECEPTOR BETA2; ESTROGEN RECEPTOR BETA5; PROSTATE SPECIFIC ANTIGEN; UNCLASSIFIED DRUG; ISOPROTEIN;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER SURGERY; CANCER SURVIVAL; CELL INVASION; CELL MIGRATION; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; PROGNOSIS; PROSTATE CANCER; PROTEIN EXPRESSION; CELL MOTION; COHORT ANALYSIS; DISEASE FREE SURVIVAL; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; PROSTATE TUMOR; TISSUE MICROARRAY; TUMOR CELL LINE;

AGED; CELL LINE, TUMOR; CELL MOVEMENT; COHORT STUDIES; DISEASE-FREE SURVIVAL; ESTROGEN RECEPTOR BETA; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSTATIC NEOPLASMS; PROTEIN ISOFORMS; TISSUE ARRAY ANALYSIS;

EID: 77956363192     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1677/ERC-09-0294     Document Type: Article

References (62)

1. Adams JY, Leav I, Lau KM, Ho SM & Pflueger SM 2002 Expression of estrogen receptor beta in the fetal, neonatal, and prepubertal human prostate. Prostate 52 69-81.
2. Allred DC, Clark GM, Elledge R, Fuqua SA, Brown RW, Chamness GC, Osborne CK & McGuire WL 1993 Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. Journal of the National Cancer Institute 85 200-206. (Pubitemid 23046895)
3. Antal MC, Krust A, Chambon P & Mark M 2008 Sterility and absence of histopathological defects in nonreproductive organs of a mouse ERbeta-null mutant. PNAS 105 2433-2438.
4. Cammarata PR, Flynn J, Gottipati S, Chu S, Dimitrijevich S, Younes M, Skliris G & Murphy LC 2005 Differential expression and comparative subcellular localization of estrogen receptor beta isoforms in virally transformed and normal cultured human lens epithelial cells. Experimental Eye Research 81 165-175. (Pubitemid 41080098)
5. Chen JQ, Delannoy M, Cooke C & Yager JD 2004 Mitochondrial localization of ERalpha and ERbeta in human MCF7 cells. American Journal of Physiology. Endocrinology and Metabolism 286 E1011-E1022.
6. Couse JF, Curtis HS & Korach KS 2000 Receptor null mice reveal contrasting roles for estrogen receptor alpha and beta in reproductive tissues. Journal of Steroid Biochemistry and Molecular Biology 74 287-296.
7. Culig Z & Bartsch G 2006 Androgen axis in prostate cancer. Journal of Cellular Biochemistry 99 373-381.
8. Dehm SM, Schmidt LJ, Heemers HV, Vessella RL & Tindall DJ 2008 Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance. Cancer Research 68 5469-5477.
9. Dupont S, Krust A, Gansmuller A, Dierich A, Chambon P & Mark M 2000 Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes. Development 127 4277-4291.
10. Eisen M, Napp HE & Vock R 1975 Inhibition of platelet aggregation caused by estrogen treatment in patients with carcinoma of the prostate. Journal of Urology 114 93-97.
11. Ellem SJ & Risbridger GP 2009 The dual, opposing roles of estrogen in the prostate. Annals of the New York Academy of Sciences 1155 174-186.
12. Ellem SJ, Schmitt JF, Pedersen JS, Frydenberg M & Risbridger GP 2004 Local aromatase expression in human prostate is altered in malignancy. Journal of Clinical Endocrinology and Metabolism 89 2434-2441. (Pubitemid 38619887)
13. Epstein JI, Allsbrook WC Jr, Amin MB & Egevad LL 2005 The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. American Journal of Surgical Pathology 29 1228-1242.
14. Fujimura T, Takahashi S, Urano T, Ogawa S, Ouchi Y, Kitamura T, Muramatsu M & Inoue S 2001 Differential expression of estrogen receptor beta (ERbeta) and its C-terminal truncated splice variant ERbetacx as prognostic predictors in human prostatic cancer. Biochemical and Biophysical Research Communications 289 692-699. (Pubitemid 33152289)
15. Guo Z, Yang X, Sun F, Jiang R, Linn DE, Chen H, Chen H, Kong X, Melamed J, Tepper CG et al. 2009 A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth. Cancer Research 69 2305-2313.
16. Hanash KA, Taylor WF, Greene LF, Kottke BA & Titus JL 1970 Relationship of estrogen therapy for carcinoma of the prostate to atherosclerotic cardiovascular disease: a clinicopathologic study. Journal of Urology 103 467-470.
17. Heldring N, Pike A, Andersson S, Matthews J, Cheng G, Hartman J, Tujague M, Strom A, Treuter E, Warner M et al. 2007 Estrogen receptors: how do they signal and what are their targets. Physiological Reviews 87 905-931. (Pubitemid 47084672)
18. Henderson BE, Bernstein L, Ross RK, Depue RH & Judd HL 1988 The early in utero oestrogen and testosterone environment of blacks and whites: potential effects on male offspring. British Journal of Cancer 57 216-218. (Pubitemid 18085409)
19. Ho SM, Leung YK & Chung I 2006 Estrogens and antiestrogens as etiological factors and therapeutics for prostate cancer. Annals of the New York Academy of Sciences 1089 177-193. (Pubitemid 47092060)
20. Horvath LG, Henshall SM, Lee CS, Head DR, Quinn DI, Makela S, Delprado W, Golovsky D, Brenner PC, O'Neill G et al. 2001 Frequent loss of estrogen receptor-beta expression in prostate cancer. Cancer Research 61 5331-5335.
21. Huggins C & Hodges CV 2002 Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941. Journal of Urology 168 9-12.
22. Jemal A, Siegel R, Ward E, Hao Y, Xu J & Thun MJ 2009 Cancer Statistics, 2009. CA: A Cancer Journal for Clinicians 59 225-249.
23. Krege JH, Hodgin JB, Couse JF, Enmark E, Warner M, Mahler JF, Sar M, Korach KS, Gustafsson JA & Smithies O 1998 Generation and reproductive phenotypes of mice lacking estrogen receptor beta. PNAS 95 15677-15682.
24. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S & Gustafsson JA 1996 Cloning of a novel receptor expressed in rat prostate and ovary. PNAS 93 5925-5930.
25. Lai JS, Brown LG, True LD, Hawley SJ, Etzioni RB, Higano CS, Ho SM, Vessella RL & Corey E 2004 Metastases of prostate cancer express estrogen receptor-beta. Urology 64 814-820. (Pubitemid 39446081)
26. Langley RE, Godsland IF, Kynaston H, Clarke NW, Rosen SD, Morgan RC, Pollock P, Kockelbergh R, Lalani el-N, Dearnaley D et al. 2008 Early hormonal data from a multicentre phase II trial using transdermal oestrogen patches as first-line hormonal therapy in patients with locally advanced or metastatic prostate cancer. BJU International 102 442-445.
27. Leav I, Ho SM, Ofner P, Merk FB, Kwan PW & Damassa D 1988 Biochemical alterations in sex hormone-induced hyperplasia and dysplasia of the dorsolateral prostates of Noble rats. Journal of the National Cancer Institute 80 1045-1053.
28. Leav I, Lau KM, Adams JY, McNeal JE, Taplin ME, Wang J, Singh H & Ho SM 2001 Comparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma. American Journal of Pathology 159 79-92. (Pubitemid 33704195)
29. Leung YK, Mak P, Hassan S & Ho SM 2006 Estrogen receptor (ER)-beta isoforms: a key to understanding ER-beta signaling. PNAS 103 13162-13167.
30. Mak P, Leav I, Pursell B, Bae D, Yang X, Taglienti CA, Gouvin LM, Sharma VM & Mercurio AM 2010 ERbeta impedes prostate cancer EMT by destabilizing HIF-1alpha and inhibiting VEGF-mediated snail nuclear localization: implications for Gleason grading. Cancer Cell 17 319-332.
31. Matzkin H & Soloway MS 1992 Immunohistochemical evidence of the existence and localization of aromatase in human prostatic tissues. Prostate 21 309-314.
32. Michaelson MD, Cotter SE, Gargollo PC, Zietman AL, Dahl DM & Smith MR 2008 Management of complications of prostate cancer treatment. CA: A Cancer Journal for Clinicians 58 196-213.
33. Moore JT, McKee DD, Slentz-Kesler K, Moore LB, Jones SA, Horne EL, Su JL, Kliewer SA, Lehmann JM & Willson TM 1998 Cloning and characterization of human estrogen receptor beta isoforms. Biochemical and Biophysical Research Communications 247 75-78. (Pubitemid 28412528)
34. Morani A, Warner M & Gustafsson JA 2008 Biological functions and clinical implications of oestrogen receptors alfa and beta in epithelial tissues. Journal of Internal Medicine 264 128-142.
35. Nanni S, Benvenuti V, Grasselli A, Priolo C, Aiello A, Mattiussi S, Colussi C, Lirangi V, Illi B, D'Eletto M et al. 2009 Endothelial NOS, estrogen receptor beta, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer. Journal of Clinical Investigation 119 1093-1108.
36. Ockrim J, Lalani el-N & Abel P 2006 Therapy insight: parenteral estrogen treatment for prostate cancer - a new dawn for an old therapy. Nature Clinical Practice & Oncology 3 552-563.
37. Pais V, Leav I, Lau KM, Jiang Z & Ho SM 2003 Estrogen receptor-beta expression in human testicular germ cell tumors. Clinical Cancer Research 9 4475-4482.
38. Pedersen SB, Bruun JM, Hube F, Kristensen K, Hauner H & Richelsen B 2001 Demonstration of estrogen receptor subtypes alpha and beta in human adipose tissue: influences of adipose cell differentiation and fat depot localization. Molecular and Cellular Endocrinology 182 27-37. (Pubitemid 32743439)
39. Peng B, Lu B, Leygue E & Murphy LC 2003 Putative functional characteristics of human estrogen receptor-beta isoforms. Journal of Molecular Endocrinology 30 13-29. (Pubitemid 36305253)
40. Poola I 2003 Molecular assays to profile 10 estrogen receptor beta isoform mRNA copy numbers in ovary, breast, uterus, and bone tissues. Endocrine 22 101-112.
41. Poola I, Abraham J, Baldwin K, Saunders A & Bhatnagar R 2005 Estrogen receptors beta4 and beta5 are full length functionally distinct ERbeta isoforms: cloning from human ovary and functional characterization. Endocrine 27 227-238.
42. Powell E & Xu W 2008 Intermolecular interactions identify ligand-selective activity of estrogen receptor alpha/beta dimers. PNAS 105 19012-19017.
43. Prins GS 1997 Developmental estrogenization of the prostate gland. In Prostate: Basic and Clinical Aspects, ch 10, pp 247-263. Ed. KN Rajesh. Boca Raton, FL: CRC Press Inc.
44. Prins GS & Korach KS 2008 The role of estrogens and estrogen receptors in normal prostate growth and disease. Steroids 73 233-244.
45. Prins GS, Birch L, Tang WY & Ho SM 2007 Developmental estrogen exposures predispose to prostate carcinogenesis with aging. Reproductive Toxicology 23 374-382. (Pubitemid 46602925)
46. Ricke WA, McPherson SJ, Bianco JJ, Cunha GR, Wang Y & Risbridger GP 2008 Prostatic hormonal carcinogenesis is mediated by in situ estrogen production and estrogen receptor alpha signaling. FASEB Journal 22 1512-1520.
47. Rodriguez LG, Wu X & Guan JL 2005 Wound-healing assay. Methods in Molecular Biology 294 23-29.
48. Rohrmann S, Nelson WG, Rifai N, Brown TR, Dobs A, Kanarek N, Yager JD & Platz EA 2007 Serum estrogen, but not testosterone, levels differ between black and white men in a nationally representative sample of Americans. Journal of Clinical Endocrinology and Metabolism 92 2519-2525.
49. Schally AV, Redding TW & Comaru-Schally AM 1983 Inhibition of prostate tumors by agonistic and antagonistic analogs of LH-RH. Prostate 4 545-552.
50. Scher HI, Buchanan G, Gerald W, Butler LM & Tilley WD 2004 Targeting the androgen receptor: improving outcomes for castration-resistant prostate cancer. Endocrine-Related Cancer 11 459-476. (Pubitemid 39331277)
51. Scobie GA, Macpherson S, Millar MR, Groome NP, Romana PG & Saunders PT 2002 Human oestrogen receptors: differential expression of ER alpha and beta and the identification of ER beta variants. Steroids 67 985-992. (Pubitemid 35175466)
52. Shaaban AM, Green AR, Karthik S, Alizadeh Y, Hughes TA, Harkins L, Ellis IO, Robertson JF, Paish EC, Saunders PT et al. 2008 Nuclear and cytoplasmic expression of ERbeta1, ERbeta2, and ERbeta5 identifies distinct prognostic outcome for breast cancer patients. Clinical Cancer Research 14 5228-5235.
53. Skliris GP, Leygue E, Curtis-Snell L, Watson PH & Murphy LC 2006 Expression of oestrogen receptor-beta in oestrogen receptor-alpha negative human breast tumours. British Journal of Cancer 95 616-626. (Pubitemid 44325902)
54. Speirs V & Walker RA 2007 New perspectives into the biological and clinical relevance of oestrogen receptors in the human breast. Journal of Pathology 211 499-506. (Pubitemid 46502425)
55. Speirs V, Carder PJ, Lane S, Dodwell D, Lansdown MR & Hanby AM 2004 Oestrogen receptor beta: what it means for patients with breast cancer. Lancet Oncology 5 174-181. (Pubitemid 38262850)
56. Stone NN, Fair WR & Fishman J 1986 Estrogen formation in human prostatic tissue from patients with and without benign prostatic hyperplasia. Prostate 9 311-318.
57. Takase Y, Levesque MH, Luu-The V, El Alfy M, Labrie F & Pelletier G 2006 Expression of enzymes involved in estrogen metabolism in human prostate. Journal of Histochemistry and Cytochemistry 54 911-921.
58. Weihua Z, Makela S, Andersson LC, Salmi S, Saji S, Webster JI, Jensen EV, Nilsson S, Warner M & Gustafsson JA 2001 A role for estrogen receptor beta in the regulation of growth of the ventral prostate. PNAS 98 6330-6335.
59. Wirth MP, Hakenberg OW & Froehner M 2008 Adjuvant hormonal treatment - the bicalutamide early prostate cancer program. Frontiers of Radiation Therapy and Oncology 41 39-48.
60. Wong NA, Malcomson RD, Jodrell DI, Groome NP, Harrison DJ & Saunders PT 2005 ERbeta isoform expression in colorectal carcinoma: an in vivo and in vitro study of clinicopathological and molecular correlates. Journal of Pathology 207 53-60.
61. Zhang X, Leung YK & Ho SM 2007 AP-2 regulates the transcription of estrogen receptor (ER)-beta by acting through a methylation hotspot of the 0N promoter in prostate cancer cells. Oncogene 26 7346-7354. (Pubitemid 350115972)
62. Zhu X, Leav I, Leung YK, Wu M, Liu Q, Gao Y, McNeal JE & Ho SM 2004 Dynamic regulation of estrogen receptor-beta expression by DNA methylation during prostate cancer development and metastasis. American Journal of Pathology 164 2003-2012. (Pubitemid 38669349)